BECKMAN GAINING $400 MIL. HEMATOLOGY BUSINESS AS PART OF $875 MIL. COULTER ACQUISITION, ROUNDING OUT HOSPITAL LAB OFFERINGS; DEAL TO CLOSE BY YEAR END
This article was originally published in The Gray Sheet
Executive Summary
Beckman Instruments' acquisition of Coulter would give the company the market leader in hematology systems, rounding out the firm's analyzer offerings and enabling it to cover all of the routine tests performed by hospitals. Beckman announced a definitive agreement to acquire privately held Coulter for $875 mil. cash on Sept. 2.